Fu et al. [50], Scheipner et al. [48], Wang et al. [52], and Bezen et al. [53] found that high values of the AST/ALT ratio were associated with a worse prognosis in non-metastatic cancers. This evidence concerns the gene GPT and metastatic malignant neoplasm.